Rayonier Inc.
NYSE:RYNREIT - Specialty
+$0.39 today
- Market cap
- $6.23B
- Beta
- 0.92
- P/E (TTM)
- 7.1
- EPS (TTM)
- $2.99
- Dividend yield
- 11.67%
Volume 2.85M
Average 2.49M
RYN Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Rayonier Inc.NYSE: RYN
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How RYN compares with its peers on the latest reported figures
- RYN's LTM Jun 2026 research & development of $0 is the highest of the 9 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for RYN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding RYN) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for RYN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.11B | 909.07M | 1.06B | 1.26B | 484.5M |
| Cost of Revenue | 796.12M | 688.28M | 762.57M | 784.83M | 327.2M |
| Gross Profit | 313.48M | 220.79M | 294.36M | 478.16M | 157.3M |
| Gross Margin | 28.3% | 24.3% | 27.9% | 37.9% | 32.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 57.79M | 64.67M | 74.77M | 74.42M | 0 |
| Operating Expenses | 43.71M | 54.97M | 83.08M | 75.7M | 74M |
| Depreciation & Amortization | 155.72M | 147.34M | 136.57M | 113.85M | 106.45M |
| EBITDA | 425.78M | 315.73M | 368.52M | 526.8M | 207.35M |
| EBITDA Margin | 38.4% | 34.7% | 34.9% | 41.7% | 42.8% |
| Operating Income | 269.78M | 165.82M | 211.28M | 402.47M | 83.3M |
| Operating Margin | 24.3% | 18.2% | 20.0% | 31.9% | 17.2% |
| Interest Income | 200K | 2.6M | 20.63M | 10.48M | 24.3M |
| Interest Expense | 44.9M | 36.2M | 48.3M | 36.92M | 26.3M |
| Other Income / Expenses | (44.63M) | (33.64M) | (27.67M) | (26.43M) | (8.7M) |
| Income Before Tax | 225.15M | 132.18M | 183.62M | 376.03M | 74.6M |
| Pre-Tax Margin | 20.3% | 14.5% | 17.4% | 29.8% | 15.4% |
| Income Tax Expense | 14.66M | 9.39M | 5.12M | 7.05M | 500K |
| Net Income | 152.55M | 107.08M | 173.49M | 359.15M | 474.4M |
| Net Margin | 13.7% | 11.8% | 16.4% | 28.4% | 97.9% |
| EPS (Basic) | 1.08 | 0.73 | 1.19 | 2.41 | 0.44 |
| EPS (Diluted) | 1.08 | 0.73 | 1.17 | 2.39 | 0.44 |
| Weighted Avg Shares | 140.81M | 146.21M | 148.05M | 148.84M | 154.76M |
| Weighted Avg Shares (Diluted) | 145.3M | 150.15M | 151.07M | 152.1M | 158.71M |
Rayonier Inc.
NYSE:RYN
Intrinsic Alpha fair value
Locked
Current Price
$21.01
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.